Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Healthcare Medical Devices
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

GlobeNewswire May 8, 2019

EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical Services

PR Newswire April 30, 2019

OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial Officer

GlobeNewswire April 29, 2019

OptimizeRx Sets First Quarter 2019 Conference Call for Wednesday, May 8, 2019 at 4:30 p.m. ET

GlobeNewswire April 26, 2019

OptimizeRx to Present at Investor Conferences in May

GlobeNewswire April 23, 2019

OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel Adds

GlobeNewswire April 8, 2019

OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care

GlobeNewswire March 20, 2019

OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11

GlobeNewswire March 4, 2019

OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year

GlobeNewswire February 26, 2019

OptimizeRx Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 26, 2018 at 4:30 p.m. ET

GlobeNewswire February 13, 2019

OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care Costs with Patients

GlobeNewswire February 11, 2019

OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Multi-Specialty Digital Health Panel

GlobeNewswire February 7, 2019

OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare

GlobeNewswire January 29, 2019

OptimizeRx Announces Pricing of Public Offering of Common Stock

GlobeNewswire December 18, 2018

OptimizeRx Announces Proposed Public Offering of Common Stock

GlobeNewswire December 17, 2018

OptimizeRx Joins MSCI USA Microcap Index

GlobeNewswire November 30, 2018

OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018

Accesswire November 28, 2018

Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire November 15, 2018

OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16

GlobeNewswire November 7, 2018

OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS

GlobeNewswire November 5, 2018